REDUCED PHOSPHATE INTAKE IN "NORMO-PHOSPHATEMIC" CHRONIC KIDNEY DISEASE PATIENTS

减少“正磷酸盐”慢性肾病患者的磷酸盐摄入量

• 批准号: 7607072
• 负责人: MYLES S WOLF
• 金额: $ 2.31万
• 依托单位: MASSACHUSETTS GENERAL HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-12-01 至 2007-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7607072
• 关键词: Calcitriol; Chronic Kidney Failure; Computer Retrieval of Information on Scientific Projects Database; Data; Development; Funding; Grant; Institution; Intake; Patients; Purpose; Research; Research Personnel; Resources; Secondary Hyperparathyroidism; Source; United States National Institutes of Health; inorganic phosphate

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purposes of this proposal are to (1) establish the primacy of phosphate loading, even without hyperphosphatemia, in the development of secondary hyperparathyroidism and (2) develop pilot data of a treatment strategy that manipulates phosphate loading in an effort to ameliorate the development of secondary hyperparathyroidism by increasing endogenous calcitriol levels, which itself along with decreased phosphate levels may be potential survival factors.

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项建议的目的是(1)确立即使没有高磷血症，磷酸盐负荷在继发性甲状旁腺功能亢进症发生中的首要地位，以及(2)建立操纵磷酸盐负荷的治疗策略的初步数据，以努力通过增加内源性骨化三醇水平来改善继发性甲状旁腺功能亢进症的发展，骨化三醇本身以及磷酸盐水平的降低可能是潜在的生存因素。